Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jaillon

Showing results (141-150 of 195) with videos related to

Pageof 20
Sort By:
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 26, 2002
[Efficacy and tolerance of propafenone after correction of atrial fibrillation: PEPS pharmaco-epidemiologic study]T Simon, M Mary-Krause, C Funck-Brentano, et al.
British Journal of Clinical Pharmacology|September 1, 1996
Influence of liver cirrhosis on sertraline pharmacokineticsJ L Démolis, P Angebaud, J D Grangé, et al.
British Journal of Clinical Pharmacology|October 6, 1999
Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteersI Ragueneau, J M Poirier, N Radembino, et al.
Circulation|February 1, 1991
Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humansC Funck-Brentano, Y Kibleur, F Le Coz, et al.
Clinical Pharmacology and Therapeutics|September 1, 1991
Influence of amiodarone on genetically determined drug metabolism in humansC Funck-Brentano, E Jacqz-Aigrain, A Leenhardt, et al.
British Journal of Clinical Pharmacology|November 14, 1997
Effects of tedisamil, atenolol and their combination on heart and rate-dependent QT interval in healthy volunteersJ L Démolis, C Martel, C Funck-Brentano, et al.
Pharmacogenetics|November 3, 2001
Early acenocoumarol overanticoagulation among cytochrome P450 2C9 poor metabolizersC Verstuyft, S Morin, A Robert, et al.
Fundamental & Clinical Pharmacology|January 1, 1996
Assessment of CYP2D6 activity in very elderly healthy subjectsM A Laurent-Kenesi, E Jacqz-Aigrain, J L Lejonc, et al.
Journal of Hepatology|January 1, 1985
Intrinsic hepatic clearance and Child-Turcotte classification for assessment of liver function in cirrhosisJ C Barbare, R E Poupon, P Jaillon, et al.
Clinical Pharmacology and Therapeutics|June 1, 1997
Influence of the CYP1A2 inhibitor fluvoxamine on tacrine pharmacokinetics in humansL Becquemont, I Ragueneau, M A Le Bot, et al.
Pageof 20

Showing results (141-150 of 195) with videos related to

Sort By:
Pageof 20
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 26, 2002
[Efficacy and tolerance of propafenone after correction of atrial fibrillation: PEPS pharmaco-epidemiologic study]T Simon, M Mary-Krause, C Funck-Brentano, et al.
British Journal of Clinical Pharmacology|September 1, 1996
Influence of liver cirrhosis on sertraline pharmacokineticsJ L Démolis, P Angebaud, J D Grangé, et al.
British Journal of Clinical Pharmacology|October 6, 1999
Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteersI Ragueneau, J M Poirier, N Radembino, et al.
Circulation|February 1, 1991
Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humansC Funck-Brentano, Y Kibleur, F Le Coz, et al.
Clinical Pharmacology and Therapeutics|September 1, 1991
Influence of amiodarone on genetically determined drug metabolism in humansC Funck-Brentano, E Jacqz-Aigrain, A Leenhardt, et al.
British Journal of Clinical Pharmacology|November 14, 1997
Effects of tedisamil, atenolol and their combination on heart and rate-dependent QT interval in healthy volunteersJ L Démolis, C Martel, C Funck-Brentano, et al.
Pharmacogenetics|November 3, 2001
Early acenocoumarol overanticoagulation among cytochrome P450 2C9 poor metabolizersC Verstuyft, S Morin, A Robert, et al.
Fundamental & Clinical Pharmacology|January 1, 1996
Assessment of CYP2D6 activity in very elderly healthy subjectsM A Laurent-Kenesi, E Jacqz-Aigrain, J L Lejonc, et al.
Journal of Hepatology|January 1, 1985
Intrinsic hepatic clearance and Child-Turcotte classification for assessment of liver function in cirrhosisJ C Barbare, R E Poupon, P Jaillon, et al.
Clinical Pharmacology and Therapeutics|June 1, 1997
Influence of the CYP1A2 inhibitor fluvoxamine on tacrine pharmacokinetics in humansL Becquemont, I Ragueneau, M A Le Bot, et al.
Pageof 20